TARSUS PHARMACEUTICALS, INC. Taxes Payable, Current
TARSUS PHARMACEUTICALS, INC. (TARS) had Taxes Payable, Current of $2.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-06
- 2026-06-30: Taxes Payable, Current $2.10M.
- 2026-03-31: Taxes Payable, Current $563.00K.
- 2025-12-31: Taxes Payable, Current $1.81M.
- 2024-12-31: Taxes Payable, Current $0.00.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-06-30 | $2.10M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $563.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.81M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |